Skip to content

IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN

IntErnational Non-randomized, Single-arm, Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01705080
Acronym
EnligHTN-II
Enrollment
276
Registered
2012-10-12
Start date
2013-01-17
Completion date
2019-11-27
Last updated
2021-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Hypertension

Keywords

Renal Denervation, Renal artery, EnligHTN™ Renal Denervation System, Renal Artery Ablation

Brief summary

The purpose of this post market clinical investigation is to further evaluate the safety and performance of the EnligHTN™ Renal Denervation System in the treatment of patients with uncontrolled hypertension.

Detailed description

This is a post market, prospective, multicenter, non-randomized, single arm study of the EnligHTN™ Renal Denervation System. Approximately 500 subjects with uncontrolled hypertension will undergo renal artery ablation at approximately 40 investigational sites located internationally and will be followed up to five years post procedure.

Interventions

DEVICEEnligHTN

Renal artery ablation with EnligHTN system used for all groups

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is ≥ 18 years of age at time of consent * Subject must be able and willing to provide written informed consent * Subject must be able and willing to comply with the required follow-up schedule * Subject has office Systolic Blood Pressure ≥ 140 mmHg at confirmatory visit * Subject has a daytime mean Systolic Ambulatory Blood Pressure \> 135 mmHg within 90 days prior to procedure * Subject has established hypertension (diagnosed ≥12 month prior to baseline) and is on a guideline based drug regimen at a stable and fully tolerated dose consisting of ≥ 3 anti-hypertensive medications (including 1 diuretic) or subject has a documented drug intolerance to 2 or more of the 4 major classes of anti-hypertensives (ACE/ARB, Calcium Channel Blockers, Beta Blockers, or diuretic) and is unable to take 3 anti-hypertensive drugs.

Exclusion criteria

* Subject has significant renovascular abnormalities such as renal artery stenosis \> 30% * Subject has undergone prior renal angioplasty, renal denervation, indwelling renal stents, and/or abdominal aortic stent grafts * Subject has hemodynamically significant valvular heart disease as determined by study investigator * Subject has a life expectancy less than 12 months, as determined by the Investigator * Subject is participating in another clinical study which has the potential to impact their hypertension management (pharmaceutical/device/homeopathic) * Subject is pregnant, nursing, or of childbearing potential and is not using adequate contraceptive methods * Subject has active systemic infection * Subject has renal arteries with diameter(s) \< 4 mm in diameter * Subject has an estimated GFR \<15 mL/min per 1.73 m\^2 using the MDRD formula * Subject had a renal transplant or is awaiting a renal transplant * Subject has blood clotting abnormalities

Design outcomes

Primary

MeasureTime frameDescription
Mean Reduction in Office Systolic Blood Pressure From Baseline to 6 MonthsBaseline to 6 monthsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Secondary

MeasureTime frameDescription
Midterm Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 6 Months6 monthsThe new renal artery stenosis (\>50%) and/or aneurysm at the site of ablation per Renal Artery Imaging (CT/MR) was summarized at each follow-up visit as the percentage of patients who have stenosis and/or aneurysm. Kaplan-meier analysis was performed on the time to the first new renal artery stenosis and/or aneurysm at the site of ablation, as appropriate.
Midterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 MonthsConfirmatory visit to 6 monthsRenal function change based on eGFR was summarized by computing the change of the eGFR at each follow-up visit compared to baseline for each patient with data available in both time points and calculating the mean and standard deviation of the eGFR change at those intervals.
Acute Safety: Percentage of Participants With Peri-procedural Events Within 30 Days Post-procedure30 days post procedureThe peri-procedural events occurring within 30 days post procedure were summarized as the percentage of the number of participants with peri-procedural events within 30 days post procedure compared to the number of participants at baseline for that population.
Long Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 2 Years2 yearsThe new renal artery stenosis (\>50%) and/or aneurysm at the site of ablation per RenalArtery Imaging (CT/MR) was summarized at each follow-up visit as the percentage of patients who have stenosis and/or aneurysm. Kaplan-meier analysis was performed onthe time to the first new renal artery stenosis and/or aneurysm at the site of ablation, as appropriate.
Long Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 5 Years5 yearsThe new renal artery stenosis (\>50%) and/or aneurysm at the site of ablation per RenalArtery Imaging (CT/MR) was summarized at each follow-up visit as the percentage of patients who have stenosis and/or aneurysm. Kaplan-meier analysis was performed onthe time to the first new renal artery stenosis and/or aneurysm at the site of ablation, as appropriate.
Long Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 YearsConfirmatory visit to 2 yearsRenal function change based on eGFR was summarized by computing the change of the eGFR at each follow-up visit compared to baseline for each patient with data available in both time points and calculating the mean and standard deviation of the eGFR change at those intervals.
Long Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 YearsConfirmatory visit to 5 yearsRenal function change based on eGFR was summarized by computing the change of the eGFR at each follow-up visit compared to baseline for each patient with data available in both time points and calculating the mean and standard deviation of the eGFR change at those intervals.
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 MonthsBaseline to 6 months24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 MonthsBaseline to 6 months24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Office Diastolic Blood Pressure From Baseline to 6 MonthsBaseline to 6 monthsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Percentage of Participants Achieved Office Systolic Blood Pressure < 140 mmHg at 6 Months6 monthsThe percentage of participants achieved office systolic blood pressure \<140 mmHg at 6 months visit was computed as the percentage of the ratio of number of participants who achievied office systolic blood pressure \<140 mmHg at 6 months visit to the number of participants with data available in 6 months visit.
Mean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline to 1 yearOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline to 2 yearsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline to 3 yearsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline to 4 yearsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline to 5 yearsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline to 1 yearOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline to 2 yearsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline to 3 yearsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline to 4 yearsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline to 5 yearsOffice blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline to 1 year24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline to 2 years24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline to 3 years24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline to 4 years24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline to 5 years24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline to 1 year24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline to 2 years24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline to 3 years24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline to 4 years24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.
Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline to 5 years24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Countries

Australia, France, Germany, Greece, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, United Kingdom

Participant flow

Recruitment details

A total of 276 subjects who underwent renal artery ablation fell into the analysis population of three predefined arms at 33 investigational sites located throughout Europe and Australia. The enrollment began on January 2013 and the last subject was enrolled on 06 September, 2016. The patients last follow-up visit occurred on 27 November, 2019.

Pre-assignment details

Among the 353 subjects who were screened initially, 66 subjects did not receive the renal artery ablation procedure, 11 subjects received procedure but did not satisfy the definition of any arm. The 11 subjects who received RND procedure were followed up for exploratory analysis and considered as unassigned arm. Of these subjects, 5 subjects completed the study, 6 subjects were withdrawn prior to study completion. Hence they were excluded during the endpoint and safety analyses.

Participants by arm

ArmCount
A - EnligHTN for Severe Resistant HTN
* Office systolic Blood Pressure ≥160 mmHg * Participant is taking ≥3 anti-hypertensive medications (including 1 diuretic), or participant has documented drug intolerance to 2 or more of the 4 major classes of anti-hypertensives (ACE/ARB, Calcium Channel Blockers, Beta Blockers, or diuretic) and is unable to take 3 anti-hypertensive drugs. * Participant has an estimated GFR ≥45 mL/min per 1.73 m\^2 using the Modification of Diet in Renal Disease (MDRD) formula EnligHTN: Renal artery ablation with EnligHTN system used for all groups
147
B - EnligHTN for Resistant HTN
* Office systolic Blood Pressure ≥140 mmHg * Participant is taking ≥3 anti-hypertensive medications (including 1 diuretic), or participant has documented drug intolerance to 2 or more of the 4 major classes of anti-hypertensives (ACE/ARB, Calcium Channel Blockers, Beta Blockers, or diuretic) and is unable to take 3 anti-hypertensive drugs. * Participant has an estimated GFR ≥45 mL/min per 1.73 m\^2 using the Modification of Diet in Renal Disease (MDRD) formula EnligHTN: Renal artery ablation with EnligHTN system used for all groups
101
C - EnligHTN for Resistant HTN & CKD
* Office systolic Blood Pressure ≥140 mmHg * Participant is taking ≥3 anti-hypertensive medications (including 1 diuretic), or participant has documented drug intolerance to 2 or more of the 4 major classes of anti-hypertensives (ACE/ARB, Calcium Channel Blockers, Beta Blockers, or diuretic) and is unable to take 3 anti-hypertensive drugs. * Participant has an estimated ≥15 GFR \<45 mL/min per 1.73 m\^2 using the Modification of Diet in Renal Disease (MDRD) formula EnligHTN: Renal artery ablation with EnligHTN system used for all groups
28
Total276

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyDeath446
Overall StudyMissed visit1041
Overall StudyWithdrawal by Subject61449

Baseline characteristics

CharacteristicA - EnligHTN for Severe Resistant HTNTotalC - EnligHTN for Resistant HTN & CKDB - EnligHTN for Resistant HTN
24-hour ambulatory blood pressure
Diastolic
88.9 mmHg
STANDARD_DEVIATION 13.1
87.6 mmHg
STANDARD_DEVIATION 13.9
82.9 mmHg
STANDARD_DEVIATION 15.6
87.0 mmHg
STANDARD_DEVIATION 14.4
24-hour ambulatory blood pressure
Systolic
159.0 mmHg
STANDARD_DEVIATION 16.3
155.0 mmHg
STANDARD_DEVIATION 16.3
161.8 mmHg
STANDARD_DEVIATION 19.3
147.4 mmHg
STANDARD_DEVIATION 12.3
Age, Continuous61.6 years
STANDARD_DEVIATION 10
60.9 years
STANDARD_DEVIATION 10.9
68.5 years
STANDARD_DEVIATION 8
58.0 years
STANDARD_DEVIATION 11.8
Office Blood Pressure
Diastolic
97.1 mmHg
STANDARD_DEVIATION 16.3
94.3 mmHg
STANDARD_DEVIATION 15.2
90.6 mmHg
STANDARD_DEVIATION 13.2
91.2 mmHg
STANDARD_DEVIATION 13.3
Office Blood Pressure
Systolic
180.4 mmHg
STANDARD_DEVIATION 22.3
172.9 mmHg
STANDARD_DEVIATION 22.6
177.3 mmHg
STANDARD_DEVIATION 22.3
160.8 mmHg
STANDARD_DEVIATION 17.5
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
64 Participants100 Participants10 Participants26 Participants
Sex: Female, Male
Male
83 Participants176 Participants18 Participants75 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
4 / 1474 / 1016 / 28
other
Total, other adverse events
40 / 14726 / 1019 / 28
serious
Total, serious adverse events
72 / 14738 / 10118 / 28

Outcome results

Primary

Mean Reduction in Office Systolic Blood Pressure From Baseline to 6 Months

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 6 months

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Reduction in Office Systolic Blood Pressure From Baseline to 6 Months6 Months163.2 mmHgStandard Deviation 25.1
A - EnligHTN for Severe Resistant HTNMean Reduction in Office Systolic Blood Pressure From Baseline to 6 MonthsBaseline179.9 mmHgStandard Deviation 22.3
A - EnligHTN for Severe Resistant HTNMean Reduction in Office Systolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-16.7 mmHgStandard Deviation 26.7
B - EnligHTN for Resistant HTNMean Reduction in Office Systolic Blood Pressure From Baseline to 6 Months6 Months147.9 mmHgStandard Deviation 17.2
B - EnligHTN for Resistant HTNMean Reduction in Office Systolic Blood Pressure From Baseline to 6 MonthsBaseline160.8 mmHgStandard Deviation 17.9
B - EnligHTN for Resistant HTNMean Reduction in Office Systolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-12.9 mmHgStandard Deviation 21.8
C - EnligHTN for Resistant HTN & CKDMean Reduction in Office Systolic Blood Pressure From Baseline to 6 MonthsBaseline177.1 mmHgStandard Deviation 22.7
C - EnligHTN for Resistant HTN & CKDMean Reduction in Office Systolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-18.3 mmHgStandard Deviation 25.8
C - EnligHTN for Resistant HTN & CKDMean Reduction in Office Systolic Blood Pressure From Baseline to 6 Months6 Months158.7 mmHgStandard Deviation 21.9
Secondary

Acute Safety: Percentage of Participants With Peri-procedural Events Within 30 Days Post-procedure

The peri-procedural events occurring within 30 days post procedure were summarized as the percentage of the number of participants with peri-procedural events within 30 days post procedure compared to the number of participants at baseline for that population.

Time frame: 30 days post procedure

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
A - EnligHTN for Severe Resistant HTNAcute Safety: Percentage of Participants With Peri-procedural Events Within 30 Days Post-procedure49 Participants
B - EnligHTN for Resistant HTNAcute Safety: Percentage of Participants With Peri-procedural Events Within 30 Days Post-procedure37 Participants
C - EnligHTN for Resistant HTN & CKDAcute Safety: Percentage of Participants With Peri-procedural Events Within 30 Days Post-procedure8 Participants
Secondary

Long Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 Years

Renal function change based on eGFR was summarized by computing the change of the eGFR at each follow-up visit compared to baseline for each patient with data available in both time points and calculating the mean and standard deviation of the eGFR change at those intervals.

Time frame: Confirmatory visit to 2 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 Years2 years76.4 mL/min/1.73m^2Standard Deviation 21.6
A - EnligHTN for Severe Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 YearsConfirmatory visit79.4 mL/min/1.73m^2Standard Deviation 17.4
A - EnligHTN for Severe Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 YearsChange from confirmatory visit to 2 years-3.0 mL/min/1.73m^2Standard Deviation 15.8
B - EnligHTN for Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 Years2 years77.7 mL/min/1.73m^2Standard Deviation 19
B - EnligHTN for Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 YearsConfirmatory visit78.4 mL/min/1.73m^2Standard Deviation 19
B - EnligHTN for Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 YearsChange from confirmatory visit to 2 years-0.7 mL/min/1.73m^2Standard Deviation 14.9
C - EnligHTN for Resistant HTN & CKDLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 YearsConfirmatory visit36.3 mL/min/1.73m^2Standard Deviation 8.2
C - EnligHTN for Resistant HTN & CKDLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 YearsChange from confirmatory visit to 2 years4.8 mL/min/1.73m^2Standard Deviation 13.2
C - EnligHTN for Resistant HTN & CKDLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 2 Years2 years41.1 mL/min/1.73m^2Standard Deviation 14.1
Secondary

Long Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 Years

Renal function change based on eGFR was summarized by computing the change of the eGFR at each follow-up visit compared to baseline for each patient with data available in both time points and calculating the mean and standard deviation of the eGFR change at those intervals.

Time frame: Confirmatory visit to 5 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 Years5 years67.9 mL/min/1.73 m^2Standard Deviation 20
A - EnligHTN for Severe Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 YearsConfirmatory visit77.6 mL/min/1.73 m^2Standard Deviation 14.7
A - EnligHTN for Severe Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 YearsChange from confirmatory visit to 5 years-9.7 mL/min/1.73 m^2Standard Deviation 17.3
B - EnligHTN for Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 Years5 years77.0 mL/min/1.73 m^2Standard Deviation 18.6
B - EnligHTN for Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 YearsConfirmatory visit80.8 mL/min/1.73 m^2Standard Deviation 17.2
B - EnligHTN for Resistant HTNLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 YearsChange from confirmatory visit to 5 years-3.8 mL/min/1.73 m^2Standard Deviation 15.7
C - EnligHTN for Resistant HTN & CKDLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 YearsConfirmatory visit38.6 mL/min/1.73 m^2Standard Deviation 7.5
C - EnligHTN for Resistant HTN & CKDLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 YearsChange from confirmatory visit to 5 years-1.1 mL/min/1.73 m^2Standard Deviation 14.5
C - EnligHTN for Resistant HTN & CKDLong Term Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 5 Years5 years37.5 mL/min/1.73 m^2Standard Deviation 16.5
Secondary

Long Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 2 Years

The new renal artery stenosis (\>50%) and/or aneurysm at the site of ablation per RenalArtery Imaging (CT/MR) was summarized at each follow-up visit as the percentage of patients who have stenosis and/or aneurysm. Kaplan-meier analysis was performed onthe time to the first new renal artery stenosis and/or aneurysm at the site of ablation, as appropriate.

Time frame: 2 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
A - EnligHTN for Severe Resistant HTNLong Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 2 Years2 Participants
B - EnligHTN for Resistant HTNLong Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 2 Years2 Participants
C - EnligHTN for Resistant HTN & CKDLong Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 2 Years0 Participants
Secondary

Long Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 5 Years

The new renal artery stenosis (\>50%) and/or aneurysm at the site of ablation per RenalArtery Imaging (CT/MR) was summarized at each follow-up visit as the percentage of patients who have stenosis and/or aneurysm. Kaplan-meier analysis was performed onthe time to the first new renal artery stenosis and/or aneurysm at the site of ablation, as appropriate.

Time frame: 5 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
A - EnligHTN for Severe Resistant HTNLong Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 5 Years3 Participants
B - EnligHTN for Resistant HTNLong Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 5 Years2 Participants
C - EnligHTN for Resistant HTN & CKDLong Term Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 5 Years0 Participants
Secondary

Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 1 year

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post Denervation1 year84.7 mmHgStandard Deviation 12
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline89.1 mmHgStandard Deviation 12.9
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-4.4 mmHgStandard Deviation 10.4
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post Denervation1 year81.9 mmHgStandard Deviation 12.2
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline86.2 mmHgStandard Deviation 14.1
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-4.4 mmHgStandard Deviation 13.4
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline85.4 mmHgStandard Deviation 16.3
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-7.6 mmHgStandard Deviation 14.1
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 1 Year Post Denervation1 year77.7 mmHgStandard Deviation 12.2
Secondary

Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 2 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post Denervation2 years83.8 mmHgStandard Deviation 12
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline88.6 mmHgStandard Deviation 13.2
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-4.8 mmHgStandard Deviation 10.4
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post Denervation2 years81.5 mmHgStandard Deviation 11.4
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline86.6 mmHgStandard Deviation 14.2
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-5.0 mmHgStandard Deviation 12.3
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline84.6 mmHgStandard Deviation 16.9
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-7.6 mmHgStandard Deviation 10.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 2 Years Post Denervation2 years76.9 mmHgStandard Deviation 14.8
Secondary

Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 3 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post Denervation3 years81.3 mmHgStandard Deviation 11.2
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline89.0 mmHgStandard Deviation 12.9
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-7.7 mmHgStandard Deviation 13.8
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post Denervation3 years81.2 mmHgStandard Deviation 12.9
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline87.7 mmHgStandard Deviation 14.7
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-6.5 mmHgStandard Deviation 13.9
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline81.7 mmHgStandard Deviation 14.7
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-4.9 mmHgStandard Deviation 10.5
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 3 Years Post Denervation3 years76.8 mmHgStandard Deviation 12.9
Secondary

Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 4 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post Denervation4 years80.3 mmHgStandard Deviation 12.5
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline88.4 mmHgStandard Deviation 12.5
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-8.1 mmHgStandard Deviation 14.6
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post Denervation4 years80.9 mmHgStandard Deviation 13.4
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline87.6 mmHgStandard Deviation 14.8
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-6.6 mmHgStandard Deviation 14.5
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline82.1 mmHgStandard Deviation 14.1
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-4.0 mmHgStandard Deviation 11.6
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 4 Years Post Denervation4 years78.1 mmHgStandard Deviation 12.6
Secondary

Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 5 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post Denervation5 years79.2 mmHgStandard Deviation 10.7
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline87.1 mmHgStandard Deviation 13.1
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-7.8 mmHgStandard Deviation 12.6
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post Denervation5 years78.5 mmHgStandard Deviation 11.1
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline87.9 mmHgStandard Deviation 15.6
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-9.4 mmHgStandard Deviation 13.1
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline83.2 mmHgStandard Deviation 14.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-7.2 mmHgStandard Deviation 13.1
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 5 Years Post Denervation5 years76.0 mmHgStandard Deviation 14.4
Secondary

Mean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 Months

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 6 months

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 Months6 months85.5 mmHgStandard Deviation 12.1
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 MonthsBaseline88.8 mmHgStandard Deviation 12.7
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-3.3 mmHgStandard Deviation 9.3
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 Months6 months83.0 mmHgStandard Deviation 12.5
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 MonthsBaseline86.8 mmHgStandard Deviation 14.3
B - EnligHTN for Resistant HTNMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-3.8 mmHgStandard Deviation 13.4
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 MonthsBaseline83.3 mmHgStandard Deviation 15.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-5.1 mmHgStandard Deviation 13.1
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Diastolic Blood Pressure From Baseline to 6 Months6 months78.1 mmHgStandard Deviation 13.9
Secondary

Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 1 year

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post Denervation1 year149.0 mmHgStandard Deviation 18.7
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline159.1 mmHgStandard Deviation 16.1
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-10.1 mmHgStandard Deviation 18.3
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post Denervation1 year141.7 mmHgStandard Deviation 17.3
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline146.8 mmHgStandard Deviation 11.4
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-5.1 mmHgStandard Deviation 16.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline163.9 mmHgStandard Deviation 18.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-15.8 mmHgStandard Deviation 24.3
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 1 Year Post Denervation1 year148.2 mmHgStandard Deviation 21.1
Secondary

Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 2 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post Denervation2 years148.0 mmHgStandard Deviation 17.2
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline158.5 mmHgStandard Deviation 15.8
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-10.5 mmHgStandard Deviation 18.6
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post Denervation2 years139.5 mmHgStandard Deviation 15
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline146.7 mmHgStandard Deviation 11.8
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-7.2 mmHgStandard Deviation 16
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline159.9 mmHgStandard Deviation 16.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-15.9 mmHgStandard Deviation 18.7
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 2 Years Post Denervation2 years144.0 mmHgStandard Deviation 16.7
Secondary

Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 3 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post Denervation3 years144.2 mmHgStandard Deviation 19.3
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline157.8 mmHgStandard Deviation 15.9
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-13.6 mmHgStandard Deviation 21.5
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post Denervation3 years139.8 mmHgStandard Deviation 18.1
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline147.0 mmHgStandard Deviation 11.9
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-7.2 mmHgStandard Deviation 18.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline156.0 mmHgStandard Deviation 14.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-4.8 mmHgStandard Deviation 20.5
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 3 Years Post Denervation3 years151.2 mmHgStandard Deviation 18.8
Secondary

Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 4 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post Denervation4 years142.3 mmHgStandard Deviation 19.6
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline157.2 mmHgStandard Deviation 14.5
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-14.9 mmHgStandard Deviation 22.4
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post Denervation4 years137.9 mmHgStandard Deviation 19.1
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline146.3 mmHgStandard Deviation 11.7
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-8.5 mmHgStandard Deviation 17.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline158.4 mmHgStandard Deviation 16.4
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-6.8 mmHgStandard Deviation 29.6
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 4 Years Post Denervation4 years151.6 mmHgStandard Deviation 21.2
Secondary

Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post Denervation

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 5 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post Denervation5 years140.0 mmHgStandard Deviation 17.8
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline155.2 mmHgStandard Deviation 14.9
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-15.1 mmHgStandard Deviation 22
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post Denervation5 years133.3 mmHgStandard Deviation 13.4
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline143.7 mmHgStandard Deviation 9.8
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-10.4 mmHgStandard Deviation 11.8
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline158.0 mmHgStandard Deviation 18.1
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-11.7 mmHgStandard Deviation 33.4
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 5 Years Post Denervation5 years146.3 mmHgStandard Deviation 26.3
Secondary

Mean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 Months

24-hour Ambulatory Blood Pressure measurements were taken according to Standard Joint National Committee VII Guidelines / ESC and ESH Guidelines at each follow-up visit. In the 24-hour blood pressure monitoring, the blood pressure of patient was measured every 30 minutes during the daytime and every 60 minutes during the night time. When using ABP, it was ensured that at least two measurements per hour are taken during the person's usual waking hours and 1 measurement per hour are taken during the person's usual night time hours. The average value of at least 14 measurements taken during the person's usual waking hours and average of at least 8 measurements taken during the person's usual sleeping hours were used for calculation of mean value.

Time frame: Baseline to 6 months

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 Months6 months151.2 mmHgStandard Deviation 18.2
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 MonthsBaseline158.3 mmHgStandard Deviation 15.7
A - EnligHTN for Severe Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-7.1 mmHgStandard Deviation 16.5
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 Months6 months142.7 mmHgStandard Deviation 17.3
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 MonthsBaseline147.0 mmHgStandard Deviation 12.1
B - EnligHTN for Resistant HTNMean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-4.3 mmHgStandard Deviation 17.1
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 MonthsBaseline160.4 mmHgStandard Deviation 18.9
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-8.1 mmHgStandard Deviation 24.6
C - EnligHTN for Resistant HTN & CKDMean Change in Ambulatory Systolic Blood Pressure From Baseline to 6 Months6 months152.2 mmHgStandard Deviation 15.9
Secondary

Mean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 1 year

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post Denervation1 year90.9 mmHgStandard Deviation 17.6
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline97.8 mmHgStandard Deviation 16.6
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-6.9 mmHgStandard Deviation 15
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post Denervation1 year85.5 mmHgStandard Deviation 13.7
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline91.0 mmHgStandard Deviation 13.5
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-5.5 mmHgStandard Deviation 13.2
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline91.5 mmHgStandard Deviation 13.3
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-13.0 mmHgStandard Deviation 13.3
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 1 Year Post Denervation1 year78.5 mmHgStandard Deviation 14.2
Secondary

Mean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 2 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post Denervation2 years88.2 mmHgStandard Deviation 16.6
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline97.1 mmHgStandard Deviation 16.8
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-8.9 mmHgStandard Deviation 16.5
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post Denervation2 years83.4 mmHgStandard Deviation 13
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline91.0 mmHgStandard Deviation 12.7
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-7.6 mmHgStandard Deviation 12.3
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline92.0 mmHgStandard Deviation 12.9
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-16.8 mmHgStandard Deviation 14.7
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 2 Years Post Denervation2 years75.2 mmHgStandard Deviation 14.3
Secondary

Mean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 3 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post Denervation3 years87.1 mmHgStandard Deviation 15.8
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline98.6 mmHgStandard Deviation 17.5
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-11.5 mmHgStandard Deviation 18.4
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post Denervation3 years82.9 mmHgStandard Deviation 12.8
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline92.0 mmHgStandard Deviation 13.2
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-9.0 mmHgStandard Deviation 12.6
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline91.3 mmHgStandard Deviation 13.3
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-14.7 mmHgStandard Deviation 14.5
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 3 Years Post Denervation3 years76.6 mmHgStandard Deviation 14.8
Secondary

Mean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 4 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post Denervation4 years86.2 mmHgStandard Deviation 13.5
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline97.5 mmHgStandard Deviation 17.5
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-11.3 mmHgStandard Deviation 18.2
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post Denervation4 years85.2 mmHgStandard Deviation 16.3
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline91.0 mmHgStandard Deviation 12.7
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-5.9 mmHgStandard Deviation 13.4
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline93.2 mmHgStandard Deviation 11.2
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-16.0 mmHgStandard Deviation 9.8
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 4 Years Post Denervation4 years77.2 mmHgStandard Deviation 12.3
Secondary

Mean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 5 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post Denervation5 years84.9 mmHgStandard Deviation 11.7
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline98.4 mmHgStandard Deviation 17.3
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-13.4 mmHgStandard Deviation 14.4
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post Denervation5 years85.1 mmHgStandard Deviation 16.1
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline93.1 mmHgStandard Deviation 12.8
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-8.0 mmHgStandard Deviation 14.5
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline95.8 mmHgStandard Deviation 13
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-17.1 mmHgStandard Deviation 14
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 5 Years Post Denervation5 years78.7 mmHgStandard Deviation 12.7
Secondary

Mean Change in Office Diastolic Blood Pressure From Baseline to 6 Months

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 6 months

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 6 Months6 months89.6 mmHgStandard Deviation 15.6
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 6 MonthsBaseline97.0 mmHgStandard Deviation 16.2
A - EnligHTN for Severe Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-7.4 mmHgStandard Deviation 13.9
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 6 Months6 months86.0 mmHgStandard Deviation 13.4
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 6 MonthsBaseline91.2 mmHgStandard Deviation 13.6
B - EnligHTN for Resistant HTNMean Change in Office Diastolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-5.2 mmHgStandard Deviation 12.2
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 6 MonthsBaseline91.0 mmHgStandard Deviation 13.3
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 6 MonthsChange from baseline to 6 months-13.1 mmHgStandard Deviation 10.1
C - EnligHTN for Resistant HTN & CKDMean Change in Office Diastolic Blood Pressure From Baseline to 6 Months6 months77.9 mmHgStandard Deviation 14.4
Secondary

Mean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 1 year

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-13.6 mmHgStandard Deviation 26.6
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post Denervation1 year166.4 mmHgStandard Deviation 25.6
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline180.0 mmHgStandard Deviation 22.4
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-12.3 mmHgStandard Deviation 22.6
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline160.1 mmHgStandard Deviation 17.6
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post Denervation1 year147.8 mmHgStandard Deviation 20.8
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post DenervationChange from baseline to 1 year-17.0 mmHgStandard Deviation 28.7
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post DenervationBaseline176.8 mmHgStandard Deviation 23
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 1 Year Post Denervation1 year159.8 mmHgStandard Deviation 26.6
Secondary

Mean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 2 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post Denervation2 years160.6 mmHgStandard Deviation 26.5
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline178.7 mmHgStandard Deviation 22
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-18.1 mmHgStandard Deviation 29
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post Denervation2 years144.3 mmHgStandard Deviation 19.5
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline158.5 mmHgStandard Deviation 16.6
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-14.2 mmHgStandard Deviation 20.9
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post DenervationBaseline178.0 mmHgStandard Deviation 22.4
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post DenervationChange from baseline to 2 years-24.8 mmHgStandard Deviation 27
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 2 Years Post Denervation2 years153.1 mmHgStandard Deviation 17.5
Secondary

Mean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 3 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post Denervation3 years159.1 mmHgStandard Deviation 28.5
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline179.3 mmHgStandard Deviation 21.9
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-20.2 mmHgStandard Deviation 34.1
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post Denervation3 years143.8 mmHgStandard Deviation 19.4
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline160.7 mmHgStandard Deviation 17.5
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-16.9 mmHgStandard Deviation 23.1
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post DenervationBaseline179.0 mmHgStandard Deviation 23.7
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post DenervationChange from baseline to 3 years-27.8 mmHgStandard Deviation 28.1
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 3 Years Post Denervation3 years151.2 mmHgStandard Deviation 21.3
Secondary

Mean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 4 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post Denervation4 years156.2 mmHgStandard Deviation 28.8
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline177.7 mmHgStandard Deviation 21.8
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-21.5 mmHgStandard Deviation 35.4
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post Denervation4 years144.6 mmHgStandard Deviation 25.3
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline157.6 mmHgStandard Deviation 15.4
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-13.0 mmHgStandard Deviation 24.9
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post DenervationBaseline180.4 mmHgStandard Deviation 24.1
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post DenervationChange from baseline to 4 years-33.5 mmHgStandard Deviation 24.4
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 4 Years Post Denervation4 years146.9 mmHgStandard Deviation 23.5
Secondary

Mean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post Denervation

Office blood pressure corresponds to the blood pressure measured by the doctor or the nurse/staff in the office or in the clinic during the participant visit. Office Blood Pressure measurements was recorded as the average Blood Pressure of three measurements. If there was a change in medication after the office Blood Pressure assessment was completed an additional set of office Blood Pressure measurements was performed.

Time frame: Baseline to 5 years

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post Denervation5 years151.8 mmHgStandard Deviation 22.6
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline176.2 mmHgStandard Deviation 20.3
A - EnligHTN for Severe Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-24.4 mmHgStandard Deviation 28.4
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post Denervation5 years144.4 mmHgStandard Deviation 21.8
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline160.2 mmHgStandard Deviation 16.3
B - EnligHTN for Resistant HTNMean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-15.7 mmHgStandard Deviation 24.8
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post DenervationBaseline184.8 mmHgStandard Deviation 24.6
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post DenervationChange from baseline to 5 years-32.0 mmHgStandard Deviation 25.7
C - EnligHTN for Resistant HTN & CKDMean Change in Office Systolic Blood Pressure From Baseline to 5 Years Post Denervation5 years152.8 mmHgStandard Deviation 19.1
Secondary

Midterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 Months

Renal function change based on eGFR was summarized by computing the change of the eGFR at each follow-up visit compared to baseline for each patient with data available in both time points and calculating the mean and standard deviation of the eGFR change at those intervals.

Time frame: Confirmatory visit to 6 months

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureGroupValue (MEAN)Dispersion
A - EnligHTN for Severe Resistant HTNMidterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 Months6 months79.5 mL/min/1.73m^2Standard Deviation 24.7
A - EnligHTN for Severe Resistant HTNMidterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 MonthsConfirmatory visit80.2 mL/min/1.73m^2Standard Deviation 20.2
A - EnligHTN for Severe Resistant HTNMidterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 MonthsChange from confirmatory visit to 6 months-0.7 mL/min/1.73m^2Standard Deviation 14.4
B - EnligHTN for Resistant HTNMidterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 Months6 months79.6 mL/min/1.73m^2Standard Deviation 19.6
B - EnligHTN for Resistant HTNMidterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 MonthsConfirmatory visit78.6 mL/min/1.73m^2Standard Deviation 17.6
B - EnligHTN for Resistant HTNMidterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 MonthsChange from confirmatory visit to 6 months1.1 mL/min/1.73m^2Standard Deviation 13.5
C - EnligHTN for Resistant HTN & CKDMidterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 MonthsConfirmatory visit35.3 mL/min/1.73m^2Standard Deviation 8.2
C - EnligHTN for Resistant HTN & CKDMidterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 MonthsChange from confirmatory visit to 6 months5.9 mL/min/1.73m^2Standard Deviation 11.6
C - EnligHTN for Resistant HTN & CKDMidterm Safety: Mean Change in eGFR (mL/Min/1.73m²) From Confirmatory Visit to 6 Months6 months41.3 mL/min/1.73m^2Standard Deviation 12.7
Secondary

Midterm Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 6 Months

The new renal artery stenosis (\>50%) and/or aneurysm at the site of ablation per Renal Artery Imaging (CT/MR) was summarized at each follow-up visit as the percentage of patients who have stenosis and/or aneurysm. Kaplan-meier analysis was performed on the time to the first new renal artery stenosis and/or aneurysm at the site of ablation, as appropriate.

Time frame: 6 months

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
A - EnligHTN for Severe Resistant HTNMidterm Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 6 Months0 Participants
B - EnligHTN for Resistant HTNMidterm Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 6 Months0 Participants
C - EnligHTN for Resistant HTN & CKDMidterm Safety: Percentage of Participants With New Renal Artery Stenosis and/or Aneurysm at Ablation Site at 6 Months0 Participants
Secondary

Percentage of Participants Achieved Office Systolic Blood Pressure < 140 mmHg at 6 Months

The percentage of participants achieved office systolic blood pressure \<140 mmHg at 6 months visit was computed as the percentage of the ratio of number of participants who achievied office systolic blood pressure \<140 mmHg at 6 months visit to the number of participants with data available in 6 months visit.

Time frame: 6 months

Population: The number of participants analyzed includes subjects who were available at the time of analysis

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
A - EnligHTN for Severe Resistant HTNPercentage of Participants Achieved Office Systolic Blood Pressure < 140 mmHg at 6 Months19 Participants
B - EnligHTN for Resistant HTNPercentage of Participants Achieved Office Systolic Blood Pressure < 140 mmHg at 6 Months27 Participants
C - EnligHTN for Resistant HTN & CKDPercentage of Participants Achieved Office Systolic Blood Pressure < 140 mmHg at 6 Months4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026